Hamza SA, Haddad NIA, Gawwam GA. The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study. IJASIS [Internet]. 2026 Feb. 10 [cited 2026 Oct. 23];:335-4. Available from: https://xlescience.org/index.php/IJASIS/article/view/785